Amit Munshi - Jun 1, 2023 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Director
Signature
/s/ Kim Davis, Attorney-in-Fact
Stock symbol
ZURA
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 08:45 PM
Previous filing
Mar 21, 2023
Next filing
Jun 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZURA Employee Share Option (Right to Buy) Award $0 +1.13M $0.00 1.13M Jun 1, 2023 Class A Ordinary Shares 1.13M $6.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted an option to purchase 1,130,000 Class A Ordinary Shares of the Issuer (the "Option") on June 1, 2023 (the "Grant Date"). The Option is vested and nonforfeitable as of the Grant Date. 25% of the Option shall become exercisable on June 1, 2024 and a further 2.083% of it shall become exercisable at the end of each month thereafter.